Preferential proliferation of attenuated Salmonella typhimurium within neuroblastoma
- PMID: 15185229
- DOI: 10.1016/j.jpedsurg.2004.02.042
Preferential proliferation of attenuated Salmonella typhimurium within neuroblastoma
Abstract
Background/purpose: Attenuated Salmonella typhimurium, a facultative intracellular parasite that colonizes the liver, has been shown to accumulate within extrahepatic malignancies. The authors sought to define a mechanism for attenuated Salmonella accumulation within cancer cells compared with hepatocytes.
Methods: Invasion and intracellular proliferation of attenuated Salmonella was assessed through an in vitro assay performed on neuroblasoma, osteosarcoma, hepatoma, and colon adenocarcinoma cell lines and compared with freshly isolated mouse hepatocytes.
Results: The efficiency of attenuated S typhimurium invasion into hepatocytes was greater than any malignant cell line (3.8 v 0.46; P <.04). However, the intracellular proliferation of the bacteria was most abundant within neuroblastoma, exceeding the proliferation within hepatocytes (14.3 v 6.2; P <.01).
Conclusions: Attenuated S typhimurium may prove to be an effective in vivo immunotherapy for the local delivery of therapeutic proteins to neuroblastoma.
Similar articles
-
Attenuated Salmonella typhimurium invades and decreases tumor burden in neuroblastoma.J Pediatr Surg. 2005 Jun;40(6):993-7; discussion 997-8. doi: 10.1016/j.jpedsurg.2005.03.015. J Pediatr Surg. 2005. PMID: 15991184
-
Targeted deletion of the ara operon of Salmonella typhimurium enhances L-arabinose accumulation and drives PBAD-promoted expression of anti-cancer toxins and imaging agents.Cell Cycle. 2014;13(19):3112-20. doi: 10.4161/15384101.2014.949527. Cell Cycle. 2014. PMID: 25486570 Free PMC article.
-
Deletion of Invasion Protein B in Salmonella enterica Serovar Typhimurium Influences Bacterial Invasion and Virulence.Curr Microbiol. 2015 Dec;71(6):687-92. doi: 10.1007/s00284-015-0903-x. Epub 2015 Sep 4. Curr Microbiol. 2015. PMID: 26341924
-
Tumor-targeting amino acid auxotrophic Salmonella typhimurium.Amino Acids. 2009 Sep;37(3):509-21. doi: 10.1007/s00726-009-0261-8. Epub 2009 Mar 17. Amino Acids. 2009. PMID: 19291366 Review.
-
Advances in Salmonella Typhimurium-based drug delivery system for cancer therapy.Adv Drug Deliv Rev. 2022 Jun;185:114295. doi: 10.1016/j.addr.2022.114295. Epub 2022 Apr 13. Adv Drug Deliv Rev. 2022. PMID: 35429576 Review.
Cited by
-
A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma.Vet Med Sci. 2016 Jun 6;2(3):179-190. doi: 10.1002/vms3.32. eCollection 2016 Aug. Vet Med Sci. 2016. PMID: 29067193 Free PMC article.
-
A Phase I, Dose Escalation, Single Dose Trial of Oral Attenuated Salmonella typhimurium Containing Human IL-2 in Patients With Metastatic Gastrointestinal Cancers.J Immunother. 2020 Sep;43(7):217-221. doi: 10.1097/CJI.0000000000000325. J Immunother. 2020. PMID: 32554977 Free PMC article. Clinical Trial.
-
Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model.Biologics. 2010 Mar 24;4:61-73. doi: 10.2147/btt.s9121. Biologics. 2010. PMID: 20376175 Free PMC article.
-
Attenuated Salmonella typhimurium with IL-2 gene reduces pulmonary metastases in murine osteosarcoma.Clin Orthop Relat Res. 2008 Jun;466(6):1285-91. doi: 10.1007/s11999-008-0243-2. Epub 2008 Apr 18. Clin Orthop Relat Res. 2008. PMID: 18421536 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical